Quarterly history
AUM ($B)fundS&P 500(gap = α)/ Flow in/out
Behavior signals (lifetime)
Dip response
+0.00%
trims when stocks drop
when a holding falls −10%+
Middle response
+0.00%
baseline attrition
Rally response
+0.00%
adds into rallies
when a holding rises +10%+
Top positions · 3
| Ticker | $ value | % port | YoY | Hold time |
|---|---|---|---|---|
| RAPPRapport Therapeutics, In | $223M | 55.7% | +212.0% | 1.5 yr |
| SEPNSepterna, Inc. | $149M | 37.2% | +315.0% | 1.5 yr |
| MAZEMaze Therapeutics, Inc. | $28M | 7.1% | +171.1% | 1.3 yr |
Portfolio composition (YoY)
Industry mix
Biotechnology100.0%+0.0pp$401M
Country
US100.0%+0.0pp
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%
Losers
| Ticker | Prev $ | PnL | YoY % |
|---|
Top buys this quarter · 0
No buys this quarter
Top sells this quarter · 0
No sells this quarter
Quarterly history (TTM returns)
| Period | AUM | # Pos | Return (1yr) | SPY (1yr) | Alpha (1yr) | Flow |
|---|---|---|---|---|---|---|
| 2026-03-31 | $401M | 3 | +239.77% | +17.59% | +222.18% | +0.00B |
| 2025-12-31 | $429M | 3 | +45.44% | +17.72% | +27.72% | -0.00B |
| 2025-09-30 | $353M | 3 | +123.03% | +8.12% | +114.91% | -0.02B |
| 2025-06-30 | $166M | 4 | +34.29% | +10.78% | +23.51% | -0.00B |
| 2025-03-31 | $125M | 4 | -60.00% | -4.27% | -55.74% | +0.01B |
| 2024-12-31 | $294M | 3 | — | — | — | — |